Company · CIK 1962011
Kairos Pharma, LTD.
| CIK | 1962011 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | KAPA (NYSE) |
| First annual or quarterly report | 2024-11-14 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-292686 | 2026-01-13 | 2026-01-23 | 2 | |
| 333-286662 | 2025-04-22 | 2025-04-24 | 2 | |
| 333-284569 | 2025-01-29 | 2025-02-04 | 2 | |
| 333-274805 | 2023-09-29 | 2024-09-17 | 11 |
Filings
19| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-01-23 | EFFECTDeclared effective | 333-292686 | 9999999995-26-000284 |
| 2026-01-13 | S-3Shelf registered | 333-292686 | 0001493152-26-001909 |
| 2025-04-24 | EFFECTDeclared effective | 333-286662 | 9999999995-25-001242 |
| 2025-04-22 | S-1Registration filed | 333-286662 | 0001641172-25-005602 |
| 2025-02-04 | EFFECTDeclared effective | 333-284569 | 9999999995-25-000308 |
| 2025-01-29 | S-1Registration filed | 333-284569 | 0001493152-25-004041 |
| 2025-01-03 | DRSDraft made public | 377-07661 | 0001493152-25-000210 |
| 2024-09-17 | 424B4Final prospectus | 333-274805 | 0001493152-24-036474 |
| 2024-09-16 | EFFECTDeclared effective | 333-274805 | 9999999995-24-002852 |
| 2024-08-16 | S-1/AAmendment | 333-274805 | 0001493152-24-032896 |
| 2024-06-04 | S-1/AAmendment | 333-274805 | 0001493152-24-022450 |
| 2024-05-24 | S-1/AAmendment | 333-274805 | 0001493152-24-021364 |
| 2024-05-20 | S-1/AAmendment | 333-274805 | 0001493152-24-020539 |
| 2024-05-13 | S-1/AAmendment | 333-274805 | 0001493152-24-018727 |
| 2024-05-01 | S-1/AAmendment | 333-274805 | 0001493152-24-017318 |
| 2024-02-14 | S-1/AAmendment | 333-274805 | 0001493152-24-006764 |
| 2023-12-07 | S-1/AAmendment | 333-274805 | 0001493152-23-043914 |
| 2023-09-29 | S-1Registration filed | 333-274805 | 0001493152-23-034915 |
| 2023-03-29 | DRSDraft made public | 377-06654 | 0001493152-23-009350 |